Results 21 to 30 of about 989 (143)

Comparison of Allergic Rhinitis Treatments on Utilities and Quality of Life: A MASK-air Study. [PDF]

Clin Exp Allergy
This mHealth study has shown that fixed combinations of intranasal antihistamines and corticosteroids were associated with higher quality of life than oral antihistamines and intranasal antihistamines. Both intranasal corticosteroids and oral antihistamines were associated with higher quality of life than intranasal antihistamines.
Lourenço-Silva N, Sousa-Pinto B, Bognanni A, Pereira AM, Coutinho-Almeida J, Amaral R, Brussino L, Giovannini M, Gemicioglu B, Kvedariene V, Larenas-Linnemann DE, Marques-Cruz M, Papadopoulos NG, Pham-Thi N, Regateiro FS, Toppila-Salmi SK, Samolinski B, Sastre J, Taborda-Barata L, Valiulis A, Vecillas LL, Ventura MT, Pfaar O, Fonseca JA, Zuberbier T, Klimek L, Bousquet J, Vieira RJ.   +27 more
europepmc   +2 more sources

Differential Effects of Dupilumab in a Patient With Localized Heat Urticaria, Delayed Solar Urticaria, and Symptomatic Dermographism. [PDF]

J Dermatol
ABSTRACT Physical urticaria is a subtype of chronic inducible urticaria characterized by wheals and/or angioedema triggered by physical stimuli. We report a refractory case of combined localized heat urticaria, delayed solar urticaria, and symptomatic dermographism in a 16‐year‐old girl.
Yoshitani S, Moriwaki S, Fukunaga A.
europepmc   +2 more sources

Bilastine 10 and 20 mg in paediatric and adult patients: an updated practical approach to treatment decisions

Drugs in Context, 2021
Background: Bilastine, a non-sedating H1-antihistamine, is indicated to treat the symptoms of allergic disorders (e.g. rhinoconjunctivitis and urticaria) in adults and adolescents and, more recently, in children.
Amalia Leceta, Aintzane García, Ander Sologuren, Cristina Campo   +3 more
doaj   +1 more source

Bilastine: a lifetime companion for the treatment of allergies [PDF]

, 2019
Objective: Bilastine is a potent and highly selective H1-antihistamine approved for the treatment of allergic rhinoconjunctivitis and urticaria. This article summarizes available data on the use of bilastine in the treatment of allergic disorders in ...
Church, Martin K, Tiongco-Recto, Marysia, Novàk, Zoltán, Ridolo, Erminia, Tiongco-Recto Marysia, Church Martin K., Ridolo Erminia, Novák Zoltán   +7 more
core   +2 more sources

Comparative clinical assessment of updosing of bilastine and combination of levocetirizine and hydroxyzine in chronic spontaneous urticaria

Clinical Dermatology Review, 2022
Background: Second-generation antihistamines (SGAHs) are first-line drugs in management of chronic spontaneous urticaria (CSU). However, almost 50% of the patients do not respond to standard dose of SGAH.
Bela Shah, Deval Mistry, Neha Jangid, Shikha Shah, Shruti Kamat, Dhiraj Dhoot, Gaurav Deshmukh   +6 more
doaj   +1 more source

Stability and Degradation Kinetic study of Bilastine in Solution State by RP-HPLC Method [PDF]

, 2021
Aim: The current study dealt with the degradation behavior of Bilastine and degradation kinetics of a drug in solution state. Background:  Very limited information on the effect of pH on maximum stability has been published.
Gupta, Krishna R, Tembhare, Ekta P, Ganorkar, Anvesha V, Karemore, Heera, Umekar, Milind J, Krishna R Gupta, Milind J Umekar, Ekta P Tembhare, Heera Karemore, Anvesha V Ganorkar   +9 more
core   +1 more source

Efficacy of Oral Bilastine in Comparison to Levocetirizine in Allergic RhinitisA Randomised Clinical Study [PDF]

Journal of Clinical and Diagnostic Research, 2021
Introduction: Allergic rhinitis is a heterogeneous disorder characterised by major symptoms like sneezing, itching, nasal congestion and rhinorrhea.
M VANITHA, K SOWMINI, K SANTHA SHEELA KUMARI, Resu Neha Reddy   +3 more
doaj   +1 more source

Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria [PDF]

, 2020
Bilastine, a second-generation antihistamine, is approved in Europe for the treatment of allergic rhinoconjunctivitis and urticaria in adults and children aged >= 6 years.
Garcia-Bea Aintzane, Labeaga Luis, Campo Cristina, Novák Zoltán, Vozmediano Valvanera, Rodriguez Monica, Yanez Anahi   +6 more
core   +1 more source

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF BILASTINE AND MONTELUKAST IN COMBINED DOSAGE FORM

, 2023
A rapid and precise reverse phase high performance liquid chromatographic method has been developed for the validated of Montelukast and Bilastine, in its pure form as well as in tablet dosage form.
P. Jyothi *, V. Soumya
core   +1 more source

Lack of Clinical Relevance of Bilastine-Food Interaction in Healthy Volunteers : A Wheal and Flare Study [PDF]

, 2022
The aim of this study was to compare the pharmacodynamic activity of bilastine administered under fasting and fed conditions in healthy volunteers. In this randomized, open-label, two-period, crossover study involving 24 healthy subjects, once-daily oral
Labeaga, Luis, Gich, Ignasi, Martínez, Joan, Coimbra, Jimena, Puntes, Montserrat, Campo, Cristina, Molina Perelló, Pol, Antonijoan Arbós, Rosa Ma, Joan Martínez, Cristina Campo, Rosa Antonijoan, Jimena Coimbra, Montserrat Puntes, Luis Labeaga, Ignasi Gich, Pol Molina   +15 more
core   +1 more source